BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+12.57%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$750M
AUM Growth
+$750M
(+54%)
Cap. Flow
+$209M
Cap. Flow
% of AUM
27.87%
Top 10 Holdings %
Top 10 Hldgs %
28.71%
Holding
137
New
15
Increased
36
Reduced
39
Closed
5
Top Buys
| 1 |
Align Technology
ALGN
|
$15.6M |
| 2 |
Elevance Health
ELV
|
$14.9M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$13.3M |
| 4 |
Amgen
AMGN
|
$11.8M |
| 5 |
Centene
CNC
|
$10.1M |
Top Sells
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$4.67M |
| 2 |
Stryker
SYK
|
$4.32M |
| 3 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
$2.11M |
| 4 |
Becton Dickinson
BDX
|
$1.83M |
| 5 |
Zimmer Biomet
ZBH
|
$1.83M |
Sector Composition
| 1 | Healthcare | 92.09% |
| 2 | Financials | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $31.3M | 4.17% | 251,380 +51,730 | +26% | +$6.44M |
|
|
2
Amgen
AMGN
$155B
| $25.5M | 3.4% | 155,450 +71,950 | +86% | +$11.8M |
|
3
Incyte
INCY
$16.5B
| $25M | 3.33% | 186,950 +36,550 | +24% | +$4.89M |
|
|
4
Centene
CNC
$14.3B
| $20.9M | 2.79% | 293,340 +141,710 | +93% | +$10.1M |
|
5
UnitedHealth
UNH
$281B
| $20.3M | 2.71% | 123,940 +13,940 | +13% | +$2.29M |
|
6
Gilead Sciences
GILD
$140B
| $19.7M | 2.63% | 290,428 +110,928 | +62% | +$7.53M |
|
7
Medtronic
MDT
$119B
| $19.5M | 2.6% | 242,500 -17,000 | -7% | -$1.37M |
|
|
8
Elevance Health
ELV
$71.8B
| $18.3M | 2.43% | 110,460 +89,860 | +436% | +$14.9M |
|
9
Abbott
ABT
$231B
| $18M | 2.4% | 405,500 | – | – |
|
10
Illumina
ILMN
$15.8B
| $16.9M | 2.25% | 98,944 +45,144 | +84% | +$7.7M |
|
11
Intuitive Surgical
ISRG
$170B
| $16.8M | 2.24% | 21,925 +12,925 | +144% | +$9.91M |
|
|
12
Stryker
SYK
$150B
| $16.1M | 2.15% | 122,570 -32,830 | -21% | -$4.32M |
|
|
13
Align Technology
ALGN
$10.3B
| $15.6M | 2.08% | +136,200 | New | +$15.6M |
|
14
Jazz Pharmaceuticals
JAZZ
$7.75B
| $15.5M | 2.06% | 106,600 +22,800 | +27% | +$3.31M |
|
15
Biogen
BIIB
$19.4B
| $14.6M | 1.95% | 53,500 +4,500 | +9% | +$1.23M |
|
16
Hologic
HOLX
$14.9B
| $14.6M | 1.94% | 342,490 +122,890 | +56% | +$5.23M |
|
17
Boston Scientific
BSX
$156B
| $14.2M | 1.9% | 572,000 +22,000 | +4% | +$547K |
|
|
WBA
18
DELISTED
Walgreens Boots Alliance
WBA
| $13.3M | 1.78% | +160,409 | New | +$13.3M |
|
19
Ligand Pharmaceuticals
LGND
$3.15B
| $12.5M | 1.67% | 118,540 -5,990 | -5% | -$634K |
|
|
BCR
20
DELISTED
CR Bard Inc.
BCR
| $12M | 1.6% | 48,430 -2,670 | -5% | -$664K |
|
|
AKRX
21
DELISTED
Akorn, Inc.
AKRX
| $11.9M | 1.59% | 494,600 +34,600 | +8% | +$833K |
|
22
Edwards Lifesciences
EW
$47.8B
| $11.8M | 1.57% | 125,000 | – | – |
|
23
Teva Pharmaceuticals
TEVA
$21.1B
| $11.8M | 1.57% | 366,172 +131,182 | +56% | +$4.21M |
|
|
SHPG
24
DELISTED
Shire pic
SHPG
| $11.4M | 1.53% | 65,700 +41,700 | +174% | +$7.27M |
|
25
Regeneron Pharmaceuticals
REGN
$61.5B
| $11.4M | 1.51% | 29,300 -3,000 | -9% | -$1.16M |
|